Publication:
Hydrocortisone, heparin, and peripheral intravenous infusion

dc.contributor.authorC. Roongpisuthipongen_US
dc.contributor.authorO. Puchaiwatananonen_US
dc.contributor.authorS. Songchitsomboonen_US
dc.contributor.authorS. Kanjanapanjapolen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-02-27T04:27:42Z
dc.date.available2018-02-27T04:27:42Z
dc.date.issued1994-08-08en_US
dc.description.abstractWe studied the effect of low-dose hydrocortisone and heparin added to peripheral intravenous fluid on episodes and severity of thrombophlebitis. Osmolal solutions of 860 mOsm/kg H 2 O with heparin and hydrocortisone (feed A) and without heparin and hydrocortisone (feed B) were infused into surgical and ear, nose, and throat patients for peripheral intravenous nutrition. The addition of heparin (500 U/L) and hydrocortisone (10 mg/L) in 10% dextrose in half-strength normal saline and 500 ml 5% crystalline amino acid solution infused simultaneously via a Y line significantly reduced the episodes and severity of thrombophlebitis. Thus, the administration of low dose hydrocortisone and heparin with peripheral fluids is beneficial in preventing thrombophlebitis.en_US
dc.identifier.citationNutrition. Vol.10, No.3 (1994), 211-213en_US
dc.identifier.issn08999007en_US
dc.identifier.other2-s2.0-0027998699en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/9648
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0027998699&origin=inwarden_US
dc.subjectMedicineen_US
dc.subjectNursingen_US
dc.titleHydrocortisone, heparin, and peripheral intravenous infusionen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0027998699&origin=inwarden_US

Files

Collections